CALADRIUS BIOSCIENCES INC (CLBS) Stock Analyst Ratings
USA - NASDAQ:CLBS - US1280582032 - Common Stock
0.4264 USD
-0.08 (-16.44%)
0.421 USD
-0.01 (-1.27%)
ChartMill assigns a Buy % Consensus number of 83% to CLBS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.59. This target is 976.45% above the current price.
CLBS was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CLBS.
In the previous month the buy percentage consensus was at a similar level.
CLBS was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-03-03 | Brookline Capital | Maintains | Buy |
CALADRIUS BIOSCIENCES INC / CLBS FAQ
Can you provide the average price target for CALADRIUS BIOSCIENCES INC stock?
8 analysts have analysed CLBS and the average price target is 4.59 USD. This implies a price increase of 976.45% is expected in the next year compared to the current price of 0.4264.
What is the consensus rating for CLBS stock?
The consensus rating for CALADRIUS BIOSCIENCES INC (CLBS) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CLBS stock?
The number of analysts covering CALADRIUS BIOSCIENCES INC (CLBS) is 8.